Most of AuNPs sensors utilize colour changes of the solution, which can be modulated by the aggregation of the nanoparticles. When AuNPs are in a colloidal dispersion the colour of the solution is reddish, changing to bluish upon their aggregation.
The selectivity of the sensor is achieved by modifying AuNPs with structures, such as antibodies, 11 peptides, 12 nucleic acids 13 or small molecules, 14 which are able to recognize corresponding targets. In the presence of the matching ligand, the AuNP sensor aggregates, resulting in the observed colour change.
Other sensors are based on the fluorescence quenching properties of AuNPs. In this case, the fluorescence of organic dyes is modulated by the proximity to the nanoparticle. The interaction with the target induces a conformational change of the structure enabling the detection of a fluorescent signal. This strategy has been employed in the detection of DNA sequences where AuNPs are modified with fluorescent molecular beacons. 15 Due to the hairpin structure of the molecular beacon the fluorescent molecule is close to the nanoparticle in the absence of the target sequence. In the presence of the complementary DNA or RNA strand the molecular beacon undergoes a structural change placing the fluorescent molecule away from the nanoparticle unquenching the fluorescent signal. Herein we report a gene sensor using AuNPs modified with molecular beacon-like structures that bear a cholesterol derivative. In the absence of the target sequence the cholesterol molecules are buried inside the nanostructure, stabilizing the nanostructure in aqueous media. In the presence of the target sequence the hairpin unfolds, exposing the cholesterol units to the water molecules (Scheme 1). Hydrophobic molecules have been employed to induce the aggregation of lipid particles, 16 but in this case we have used a cholesterol derivative to build a gene sensor using AuNPs modified with oligonucleotides. We are able to show a significant change in the solubility of our nanoparticles when the cholesterol moiety is exposed to the water molecules. This alteration can be seen by the naked eye since the particles precipitate in the presence of the target sequence, reducing the colour intensity of the solution. Related gene sensors based on the aggregation of oligonucleotides covalently attached to AuNPs require the use of two sets of modified AuNPs to promote the aggregation. 17 In our case, only one system is needed. To evaluate this approach we have selected three target genes in which specific single-point mutations are involved in different diseases: GNAQ, PDE6B and KRAS. GNAQ mutations are present in over 50% of uveal melanomas, 18 mutant PDE6B is a gene responsible for retinitis pigmentosa (RP) and KRAS is frequently mutant in pancreatic cancer, among other malignant diseases. 19 AuNPs were prepared following the established procedure developed by Turkevich, which yields nanoparticles of 13 nm size in aqueous solution. 20 Then, the nanoparticles were functionalized with modified oligonucleotides to yield the final sensor. The oligonucleotides used were designed to target the selected genes and were prepared with two modifications: (1) a cholesterol derivative at the 5 0 -end and (2) a dithiolane derivative at the 3 0 -end. The cholesterol group is used to modulate the hydrophobic properties of the nanoparticle in the presence of the target gene. The dithiolane moiety allows the functionalization of AuNPs due to the high affinity of sulfur to gold. This group has several advantages compared with the standard thiol groups previously used in the preparation of modified oligonucleotides. First, deprotection of dithiolane group is not required and oligonucleotides can be used after standard synthesis and deprotection. Second, binding is fast and modified AuNPs are more stable compared to AuNPs bearing thiol modified oligonucleotides. We have prepared a modified solid support to introduce this group at the 3 0 -end of the oligonucleotides (ESI †).
The required oligonucleotides were prepared in a MerMade4 DNA synthesizer using the modified CPG, and commercial phosphoramidites, including the cholesterol molecule. The oligonucleotide strands were purified by polyacrylamide gel electrophoresis and characterized using MALDI-TOF. These oligonucleotides were incubated with AuNPs overnight and modified nanostructures were purified by iterative centrifugation. Modified AuNPs were obtained as a well dispersed and very stable solution in water. Particles can be stored at Q5 À20 1C for months without loss of their properties.
Next, the modified AuNPs were tested for their ability to detect the complementary oligonucleotide. A solution of the modified gold nanoparticles was incubated with different oligonucleotides: (1) the corresponding target, (2) a scramble and (3) a mismatched sequence. The results were compared to evaluate the selectivity of modified AuNPs for recognizing the target oligonucleotide.
Optimization of the experimental conditions by adjusting the amount of NaCl as well as the incubation time allowed us to detect single-point mutations at 32 nM in the case of KRAS and at 3.2 nM in the case of PDE6B and GNAQ (ESI †). The best results were obtained with the sensors designed to detect GNAQ. In this case, two different sets of sensors were able to detect the desired mutation. One set was designed to detect the wild-type sequence (GQ-WT) and another to detect the mutated one (GQ-MUT).
In our experiments we did not observe a change in color from reddish to bluish, as we had expected from reported sensing systems that involve gold nanoparticles. However, we noticed a decrease in the saturation of the reddish color and the formation of insoluble larger particles (ESI †). The precipitate is induced in the presence of the target oligonucleotide, which opens the hairpin structure exposing the cholesterol moiety to the water. To evaluate the role of the cholesterol group in the AuNP sensor a derivative without the cholesterol moiety was prepared. Incubation of this structure with its target sequence did not yield changes in absorbance (ESI †), highlighting the key role of the cholesterol moiety in the sensor.
Our aim for the next round of experiments was to detect mutations in total mRNA extracts from different cell lines. Due to the excellent results obtained with the GNAQ sensor we focused on this gene and we used the following cell lines: OMM1.3, a uveal melanoma cell line bearing GNAQ mutation (626A > C; Q209P), C918 a uveal melanoma cell line expressing wild type GNAQ and RNA extracts from mouse liver that do not contain the GNAQ gene.
After the incubation of AuNPs designed to detect wild type GNAQ with total mRNA extracts of OMM1.3, C918 and mouse liver we were able to observe differences in absorbance indicating the detection of the wild type sequence. In Fig. 1 a drop in absorbance is observed when the wild type sequence is present. The decrease in absorbance is less intense for extracts that contain mutant GNAQ.
Nanoparticles designed to detect the single-point mutation in GNAQ showed even better results. Absorbance dropped only when cell extracts from the mutant OMM1.3 cells were used (Fig. 2) . In this case, the mutation can be detected even in the presence of a large amount of the wild-type gene (ESI †).
The detection of the mutant sequence could be observed with the naked eye. As shown in Fig. 3 , the color of the solution in tube A containing extracts from GNAQ mutant cells is less intense compared to tubes B and C that hold extracts that do not contain GNAQ and wild type GNAQ respectively. In addition, a higher amount of aggregates could be detected in tube A.
In summary, we present herein a new sensor for the detection of specific DNA and RNA sequences, which does not require the use of any additional equipment to confirm the presence of a gene. The read-out of the detection can be done with the naked eye due to changes in the intensity and saturation in the colour of the solution. We want to highlight that the sensor is able to detect single-point-mutations at concentrations as low as 3.2 nM of the target sequence. Furthermore, the sensor was able to detect specific mutations in total mRNA cell extracts at low concentration without the need for prior amplification.
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